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Introduction {#sec1}
============

TP53 binding protein 1 (53BP1) is a large multi-domain protein with multiple roles in the DNA damage response ([@bib19], [@bib31]). Following DNA damage and activation of the DNA-damage-responsive protein kinase ATM, 53BP1 is recruited rapidly to nuclear foci ([@bib24]) containing the primary mark of DNA damage---phosphorylation of Ser139 close to the C terminus of the histone H2A variant---H2AX ([@bib23]), generally known as γH2AX. Although 53BP1 has a C-terminal tandem BRCT domain (BRCT~2~), which in its orthologs, *Saccharomyces cerevisiae* Rad9p and *Schizosaccharomyces pombe* Crb2, mediates binding to the equivalents of γH2AX ([@bib11], [@bib13]), the role of the 53BP1-BRCT~2~ domain remains controversial. Although some studies indicated an interaction with γH2AX ([@bib26], [@bib28]), others have contradicted this ([@bib27], [@bib29]), and a significant role for this domain in the DNA damage response has been largely discounted ([@bib4], [@bib6]).

Current models suggest that 53BP1 recruitment to ionizing radiation induced nuclear foci (IRIF) depends only indirectly on γH2AX and is instead mediated by two other post-translational modifications: (1) H2AK13/15-anchored ubiquitin chains ([@bib9]) generated by the E3 ubiquitin ligases RNF8 and RNF168, which are themselves recruited by MDC1, whose BRCT~2~ domain interaction with γH2AX is required for its own recruitment ([@bib3], [@bib21]); and (2) direct interaction of the tandem Tudor domains of 53BP1 with dimethylated H4K20 ([@bib5]) exposed by release of JMJD2A and L3MBTL1 following their ubiquitylation by RNF8 and RNF168 ([@bib1], [@bib16]).

We have re-examined the role of the 53BP1-BRCT~2~ domain and show unambiguously that it is a competent binding module for phosphorylated peptides with a clear specificity for the DNA-damage marker γH2AX, and in isolation from other parts of 53BP1 is sufficient for localization to sites of DNA damage in cells associated with γH2AX.

Structure-based mutational disruption of γH2AX binding by 53BP1 interferes with the 53BP1-dependent localization of pATM required for repair of DNA damage in regions of heterochromatin and results in a defect in the slow phase of DNA break repair in G1. These data add a third histone post-translational mark to the ligand repertoire of 53BP1, and a clear functional role for phosphopeptide binding by its BRCT~2~ domain.

Results and Discussion {#sec2}
======================

53BP1-BRCT~2~ Binds γH2AX In Vitro {#sec2.1}
----------------------------------

Comparison of the tandem BRCT domains of 53BP1 with those of MDC1 ([@bib22], [@bib27]) and Crb2 ([@bib13]) shows strong conservation of residues implicated in specific binding of phosphorylated histone H2A tails. To determine whether 53BP1 shared this property, we measured the binding of the isolated 53BP1-BRCT~2~ segment to a fluorescently labeled phosphopeptide (fluorescein-SGGKKATQApSQEY) corresponding to the last 13 residues of human γH2AX, by fluorescence polarization (see [Experimental Procedures](#sec3){ref-type="sec"}). 53BP1-BRCT~2~ bound the phosphopeptide with a K~D~ of ∼1.4 μM ([Figure 1](#fig1){ref-type="fig"}A), an affinity ∼3.5-fold lower than MDC1-BRCT~2~ (K~D~ = ∼0.4 μM) when measured under the same experimental conditions ([Figure 1](#fig1){ref-type="fig"}B), but well within the range that is highly likely to be physiologically functional. The dephosphorylated H2AX peptide showed no significant binding ([Figure 1](#fig1){ref-type="fig"}A), nor did a comparable phosphopeptide from another protein (KAP1-pS824: fluorescein-*GYG*-SLPGAGLSpSQELSGG), showing the interaction is both phospho-dependent and sequence specific ([Figure 1](#fig1){ref-type="fig"}C).

Given that γH2AX is not the only phosphorylated ligand bound specifically by other BRCT~2~ domains, we further defined the parameters of phosphopeptide recognition by 53BP1-BRCT~2~. A γH2AX peptide with an amidated C terminus (H2AX-pS139-NH~2~ or with an additional glycine (H2AX-pS139-Gly) bound 53BP1-BRCT~2~ far less tightly than the peptide with the free charged α-carboxyl ([Figure 1](#fig1){ref-type="fig"}D). (Although the phosphorylated serine in human H2AX is encoded by codon 140 of the *H2AFX* gene, the initiator methionine is removed, and therefore not generally counted in the prevalent literature. For consistency, we here refer to this residue as Ser139.) We also explored the effect on binding to 53BP1-BRCT~2~ of phosphorylation of H2AX-Tyr142, believed to mediate a switch between DNA repair and apoptosis ([@bib7]). An H2AX peptide phosphorylated on Tyr142 bound far less tightly than the γH2AX peptide, as did a peptide *bis*-phosphorylated on both Ser139 and Tyr142 ([Figure 1](#fig1){ref-type="fig"}E). These data reinforce the conclusion that the canonical DNA-damage-responsive mark γH2AX is a specific ligand of 53BP1-BRCT~2~.

To further characterize the interaction, we determined the crystal structure of 53BP1-BRCT~2~ in complex with the core DNA-binding domain of P53 and a short "pSQEY" peptide corresponding to the last four residues of γH2AX ([Figure 1](#fig1){ref-type="fig"}F; [Table S1](#mmc1){ref-type="supplementary-material"}). The phosphopeptide bound in a similar conformation to its interaction with the BRCT~2~ domain of MDC1, with the phosphate group on γH2AX-Ser139 bound by the side chain of 53BP1-Thr1737, the peptide backbone of Met1738, and the side chains of Lys1773 and Lys1814 ([Figure 1](#fig1){ref-type="fig"}G). The side-chain carboxyl of γH2AX-Glu141 interacts with the peptide backbone of 53BP1-Arg1811, while the α-carboxyl of γH2AX-Tyr142 forms ionic and hydrogen bonding interactions with the side chain of 53BP1-Arg1811, explaining the strong preference for an unblocked C terminus in our binding assays ([Figure 1](#fig1){ref-type="fig"}D). The side chain of Tyr142 protrudes into a hydrophobic pocket lined by the side chains of Leu1887, Asn1883, and the main chain of Arg1813, an interaction that would be precluded by its phosphorylation. Consistent with the structure, charge reversal mutation of Lys1814, which interacts with the phosphate on H2AX-pSer139, or Arg1811, which binds the α-carboxyl of H2AX-Tyr142, abrogated interaction of 53BP1-BRCT~2~ with the γH2AX phosphopeptide ([Figure 1](#fig1){ref-type="fig"}H). As the BRCT~2~ domain of 53BP1 is a dimer in solution, like that of its yeast homolog Crb2 ([@bib13]), we confirmed that dimerization was not affected by the phospho-binding mutations ([Figure S1](#mmc1){ref-type="supplementary-material"}).

53BP1-BRCT~2~ Binds γH2AX in Cells {#sec2.2}
----------------------------------

To determine whether the in vitro interaction that we observed for 53BP1-BRCT~2~ is reflected in its behavior in cells, we transfected HeLa cells with an eYFP~NLS~-53BP1-BRCT~2~ construct. Laser micro-irradiation of the nuclei of live transfected cells caused a distinct time-dependent accumulation of fluorescence along the laser track, consistent with recruitment of the tagged 53BP1-BRCT~2~ construct to sites of DNA damage; a construct lacking the BRCT~2~ segment or with mutations that abolish γH2AX binding in vitro did not ([Figures 2](#fig2){ref-type="fig"}A and 2B; [Movies S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}). Although it was not possible to directly image γH2AX formation in live HeLa cells, recruitment of MDC1-BRCT~2~ to the laser tracks confirms the presence of γH2AX ([Movies S3](#mmc4){ref-type="supplementary-material"}), and clear γH2AX foci could be readily visualized in fixed cells following irradiation. The lower intensity of the recruited 53BP1-BRCT~2~ compared to MDC1-BRCT~2~ is consistent with the lower affinity of 53BP1-BRCT~2~ for γH2AX we measured in vitro. Pre-treatment of the cells with KU55933, a specific inhibitor of ATM, substantially diminished γH2AX focus formation on irradiation, and this was further decreased by a DNA-PK inhibitor NU7441 ([Figure 2](#fig2){ref-type="fig"}C). When HeLa cells expressing the eYFP~NLS~-53BP1-BRCT~2~ construct were similarly pre-treated, recruitment of fluorescence to the laser stripe was greatly diminished, and with addition of NU7441, effectively abolished ([Figure 2](#fig2){ref-type="fig"}D). Consistent with this, the eYFP~NLS~-53BP1-BRCT~2~ construct did not localize to sites of DNA damage in mouse embryonic fibroblasts lacking H2AX ([Figures 2](#fig2){ref-type="fig"}E, 2F, and [S2](#mmc1){ref-type="supplementary-material"}). Finally, we immunoprecipitated the wild-type eYFP~NLS~-53BP1-BRCT~2~ construct from HeLa cell extracts and were able to detect a co-precipitating γH2AX signal in western blots that was greatly diminished in immunoprecipitates of eYFP~NLS~-53BP1-BRCT~2~ with the R1811E mutation that abrogates γH2AX binding in vitro ([Figure 2](#fig2){ref-type="fig"}G).

Taken together, these structural, biochemical, and cellular observations provide compelling evidence that the BRCT~2~ segment of 53BP1 has an inherent ability to localize to sites of DNA damage independently of other regions of the protein, and that this recruitment, which depends on phosphorylation of H2AX by DNA-damage-responsive PIKK kinases, is mediated by the clearly demonstrated ability of 53BP1-BRCT~2~ to bind γH2AX both specifically and directly.

Phospho-Binding by 53BP1-BRCT~2~ Regulates pATM Focal Localization {#sec2.3}
------------------------------------------------------------------

Having demonstrated the ability of 53BP1 to bind γH2AX directly, we sought to determine whether this ability contributed to any of the known roles of 53BP1 in the DNA damage response.

53BP1 is required for the focal localization of activated ATM, autophosphorylated on Ser1981 ([@bib2]), and MRE11-RAD50-NBS1 (MRN) complexes at sites of DNA damage, and in the consequent activation of ATM checkpoint signaling ([@bib8], [@bib17], [@bib15], [@bib19]). Consistent with this, small interfering RNA (siRNA) knockdown of 53BP1 in HeLa cells substantially diminished recruitment of activated pATM and MRN (visualized by NBS1), to nuclear ionizing radiation-induced foci (IRIF), with both of these proteins displaying a diffuse pan-nuclear distribution following irradiation ([Figures 3](#fig3){ref-type="fig"} and [S3](#mmc1){ref-type="supplementary-material"}).

Wild-type siRNA-resistant HA-tagged 53BP1 expressed in these knockdown cells, formed distinct foci itself following irradiation, and restored NBS1 and pATM foci that co-localized with those of 53BP1. However, a 53BP1 construct completely lacking the BRCT~2~ domain still formed foci of its own but failed to restore NBS1 and pATM foci. By contrast 53BP1 constructs in which the BRCT~2~ domain was present but contained mutations that disrupt binding to γH2AX (R1811E, K1814E) were able to recruit NBS1 into co-incident foci but had no effect on pATM, which retained the diffuse staining evident in the 53BP1 knockdown cells. A defect in pATM focus formation was evident with the K1814E mutant as early as 30 min post-irradiation ([Figure S3](#mmc1){ref-type="supplementary-material"}B). A 53BP1 construct with a Tudor domain mutation (Y1502L) that abolishes recruitment to DNA damage ([@bib12], [@bib5]) eliminated 53BP1 foci and did not restore focal concentration of either NBS1 or pATM.

These data confirm previous observations that 53BP1 facilitates focal concentration of NBS1 (and thereby MRN) and pATM at DNA breaks in G1 but show that in both cases this is dependent on the BRCT~2~ domain, and that focal recruitment of pATM is specifically dependent on the ability of that domain to interact with γH2AX. These data also indicate a function for the 53BP1-BRCT~2~ in mediating an additional link between MRN complexes and chromatin modification, via its phosphorylation-independent interaction with RAD50 ([@bib20]) and its phosphorylation-dependent interaction with γH2AX.

Phospho-Binding by 53BP1-BRCT~2~ Contributes to Heterochromatin Repair {#sec2.4}
----------------------------------------------------------------------

Double-strand break (DSB) repair in heterochromatin occurs more slowly than in euchromatin and requires 53BP1-dependent retention of pATM and consequent phosphorylation of the silencing factor KAP1/TRIM28 ([@bib18]), which promotes its release with consequent relaxation of the heterochromatin. HeLa cells contact-inhibited in G0/G1, and transfected with 53BP1 siRNA, displayed significantly higher numbers of γH2AX foci 16--24 hr after irradiation than mock-transfected cells, or knockdown cells expressing a wild-type 53BP1 construct ([Figure 4](#fig4){ref-type="fig"}A). Consistent with their inability to localize pATM ([Figure 3](#fig3){ref-type="fig"}B), 53BP1 constructs lacking the BRCT~2~ domain or with γH2AX-binding defective mutations failed to rescue the knockdown phenotype and resulted in significantly increased levels of γH2AX foci at later time points ([Figures 4](#fig4){ref-type="fig"}B and [S4](#mmc1){ref-type="supplementary-material"}). Simultaneous knockdown of KAP1, whose phosphorylation depends on pATM localization, reduced the number of persistent γH2AX foci seen with these mutants back down to wild-type levels ([Figure 4](#fig4){ref-type="fig"}C), confirming that these persistent foci were due to damage sites in heterochromatin ([@bib10]).

Biological Roles of 53BP1 Binding to γH2AX {#sec2.5}
------------------------------------------

To date, BRCT~2~ domains of three mammalian proteins---MCPH1, PTIP, and MDC1---have been found to specifically recognize the primary mark of DNA damage, γH2AX ([@bib30], [@bib27], [@bib25]). Our data show unambiguously that this is a property shared by the BRCT~2~ domain of 53BP1, and that this interaction plays a role in the biological functions of 53BP1---a very similar conclusion was reached by [@bib14]. This observation further strengthens the idea that 53BP1 is the functional ortholog of the fission yeast and budding yeast proteins Crb2 and Rad9p ([@bib11], [@bib13]).

Although the ability of the BRCT~2~ domain of 53BP1 to bind γH2AX contributes to efficient repair of DNA damage, it is not required for initial recruitment of 53BP1 to IRIF in the immediate response to DNA damage in G1. 53BP1 recruitment is downstream of recognition of γH2AX by MDC1, whose BRCT~2~ domain has a higher affinity for γH2AX. Nonetheless, once recruited to damaged chromatin 53BP1's interaction with γH2AX would be favored by its interaction with the other post-translational modifications it recognizes, and the γH2AX interaction might only become functionally significant at a later stage of the IRIF-centered repair processes or in specific situations such as the repair of damage in heterochromatin, as we show here.

Recruitment and retention of 53BP1 at sites of DNA damage facilitates co-localization and retention of other factors required for signaling and repair ([@bib19]). In the case of MRN, this is mediated by a phospho-independent interaction between RAD50 and the 53BP1-BRCT~2~ ([@bib15]). Regions within the MRN complex have, in turn, been implicated in recruiting and activating ATM at sites of DNA damage ([@bib20]), but it is not clear what role these play in retaining pATM in damage foci downstream of initial activation. Our data indicate that focal concentration and retention of pATM at slowly repaired sites of DNA damage in G1 ([@bib18]) is independent of MRN recruitment but dependent on 53BP1 recruitment and, significantly, the histone modifications it engages with. Thus, while removal of the ability of 53BP1 to bind γH2AX does not affect focal co-localization of MRN and 53BP1, it substantially reduces pATM localization, which, in turn, results in a defect in DSB repair in heterochromatin. These data highlight a role for the 53BP1-BRCT~2~ domain in reinforcing links between MRN complexes and chromatin modification, via its phosphorylation-independent interaction with RAD50 ([@bib18]) and its phosphorylation-dependent interaction with γH2AX.

The means by which 53BP1 facilitates pATM concentration and retention in IRIFs remains unclear. There is little indication in the literature of a direct interaction of ATM with 53BP1, although both proteins have well-documented interactions with other proteins in common. The dependence we demonstrate here on 53BP1's ability to bind γH2AX suggests that this is likely to involve complex features of local chromatin conformation and histone modifications and further work will be required to define this. It is highly likely that other of the myriad functions of 53BP1 will also involve this hitherto disregarded property of 53BP1, and work is ongoing to uncover and characterize these.

Experimental Procedures {#sec3}
=======================

See the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for full details.

Protein Expression and Purification {#sec3.1}
-----------------------------------

Proteins for biochemical and structural analysis were expressed in *E. coli* and purified by affinity and conventional chromatography.

Fluorescence Polarization Experiments {#sec3.2}
-------------------------------------

Binding to BRCT~2~ domains was determined using fluorescein-labeled peptides and His~6~-SUMO-BRCT~2~ fusion proteins. Dissociation constants (K~D~) were determined by non-linear regression to a one site-specific binding model.

Crystallization, X-Ray Diffraction Data Collection, Phasing, Model Building, and Refinement {#sec3.3}
-------------------------------------------------------------------------------------------

Crystals of P53^Core^/53BP1-BRCT~2~ were grown by vapor diffusion and soaked with the γH2AX-pS139 peptide (pSQEY) for 60 min prior to plunge-freezing in liquid nitrogen. Diffraction data were collected at the Diamond Synchrotron Lightsource, and the structure was determined by molecular replacement.

Tissue Culture, Cell Lines, and Reagents {#sec3.4}
----------------------------------------

HeLa, H2AX^+/+^, and H2AX^−/−^ mouse embryonic fibroblast (MEF) cells were cultured in DMEM supplemented with 10% (v/v) fetal calf serum (FCS), penicillin, streptomycin, and L-glutamine. Caffeine (Sigma-Aldrich) was used at a final concentration of 10 mM. ATMi (KU55933, Abcam), DNA-PKi (NU7441, Santa Cruz Biotechnology), and ATRi (ATR-kinase inhibitor II, Merck Millipore) were all used at a concentration of 10 μM, except for the CHK1 inhibitor UCN-01 (Sigma-Aldrich) that was used at a concentration of 200 nM. Cells were irradiated using a Caesium^137^ gamma source.

siRNA Depletion of 53BP1/KAP-1 and siRNA-Resistant Expression of 53BP1 {#sec3.5}
----------------------------------------------------------------------

HeLa cells were seeded at high confluence onto 35-mm plates and reverse transfected with either 53BP1-siRNA or negative control oligonucleotides diluted into serum free media Cells were cultured for a further 48 hr for efficient depletion. Subsequently cells were transfected with 53BP1 constructs rendered siRNA-resistant by three silent point mutations in the 53BP1 cDNA clone in pCMH6K (A231G, A234G, and A237C) ([@bib18]) and incubated for a further 16 hr before irradiation.

Antibodies {#sec3.6}
----------

All antibodies used were from standard commercial sources (see the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for full details).

Immunofluorescence {#sec3.7}
------------------

Cells were fixed on coverslips and washed three times before incubation at room temperature with the primary antibodies. Cells were washed a further three times before incubation with the secondary, fluorophore-coupled, antibodies, and washed a final three times before mounting on glass slides with DAPI mounting media.

Live-Cell Imaging and UV-Laser Microirradiation {#sec3.8}
-----------------------------------------------

Cells were seeded at low confluence before 53BP1 depletion by siRNA, and eYFP-SV40~NLS~-53BP1-BRCT~2~ plasmid constructs were transfected into cells. Cells were incubated for 20 min with 100 μg/ml Hoechst 34580 prior to excitation with a 405-nm laser. Protein localization was tracked over 3 min using a 488-nm laser.

GFP-Trap {#sec3.9}
--------

Stable cell lines were generated for HeLa cells transfected with wild-type or R1811E mutant forms of the eYFP-SV40~NLS~-53BP1-BRCT~2~ expression construct. Cellular lysates were generated by re-suspension of frozen pellets, and incubated with GFP-Trap A resin. Retained protein was detected by chemiluminescent western blot.
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![53BP1 BRCT~2~ Domain Binds γH2AX\
(A) Fluorescence polarization assay (closed circle) showing binding of His~6~-SUMO-53BP1-BRCT~2~ to a fluorescein-tagged phosphopeptide (Flu-SGGKKATQApSQEY) corresponding to the last 13 residues of γH2AX. Data are means of four replicates with error bars showing 1 SD, and the K~D~ (1.4 μM ± 0.15) was calculated by least-squares fitting of a one-site binding model. Removal of the phosphate group on Ser139 by addition of λ-phosphatase (open circle) abrogates the interaction. The dashed line indicates a signal level consistent with non-specific interaction.\
(B) As (A) but for His~6~-SUMO-MDC1-BRCT~2~ binding to the fluorescein-tagged γH2AX phosphopeptide.\
(C) As (A) but with a fluorescein-tagged phosphopeptide derived from the major ATM phosphorylation site on the heterochromatin protein KAP-1 ([@bib18]). No binding was observed.\
(D) As (A) but for γH2AX peptides in which the C-terminal α-carboxyl group of Tyr142 is modified by either amidation (closed circle) or addition of a further glycine residue (open circle). Both modifications substantially reduce the affinity, and no K~D~ could be determined.\
(E) As (A) but for H2AX peptides in which the side chain of Tyr142 is phosphorylated, either alone (closed circle) or in the presence of the γH2AX Ser139 phosphorylation (open circle). In both cases, phosphorylation of Tyr142 substantially diminished binding to His~6~-SUMO-53BP1-BRCT~2~.\
(F) Overview of crystal structure of a phosphopeptide corresponding to the last four residues of γH2AX bound to the BRCT~2~ domain of 53BP1. The core DNA-binding domain of P53, which is required for crystallogenesis, makes no interaction with the γH2AX peptide and is omitted for clarity.\
(G) Detail of interactions made by the tail of γH2AX with the 53BP1-BRCT~2~ domain. Carbon atoms in γH2AX are white; those of 53BP1 are rainbow colored to reflect their relative position within the protein sequence. The basic side chains of 53BP1 residues Lys1814 and Arg1811 provide neutralizing hydrogen bonding interactions with the acidic phosphate of γH2AX-pSer139 and the α-carboxyl of Tyr142, which are both required for binding of γH2AX to 53BP1-BRCT~2~; see (A) and (C).\
(H) As (A) but showing binding of the fluorescent γH2AX peptide to His~6~-SUMO-53BP1-BRCT~2~ with either an R1811E mutation (closed circle) or a K1814E mutation (open circle).](gr1){#fig1}

![53BP1 BRCT~2~ Domain Localizes to DNA Damage through Phospho-Specific Interactions\
(A) HeLa cells were reverse transfected with 53BP1 siRNA. 48 hr later, cells were transfected with eYFP-SV40~NLS~ or eYFP-SV40~NLS~-53BP1-BRCT~2~ constructs containing either wild-type or mutant BRCT domains, or eYFP-SV40~NLS~-MDC1-BRCT~2~. 16 hr after this cells were damaged using laser micro-irradiation along a line indicated by the white arrowheads, and images were recorded over 3 min. Scale bar, 10 μm.\
(B) eYFP fluorescence was tracked over 3 min to observe localization. Profiles of fluorescence intensity along the laser track in (A) were generated using Slidebook6 software (n = 30 from three experimental repeats). Error bars, 1 SD.\
(C) Cells were treated with either KU55933 (ATMi), NU7441 (DNA-PKi), or both for 1 hr prior to irradiation with 3 Gy of IR. Cells were incubated for a further 30 min before fixing and staining for γH2AX. Scale bar, 10 μm.\
(D) Cells were processed as before with the addition of either DNA-PKi, ATMi, or both for 1 hr prior to laser micro-irradiation. eYFP-fluorescence was tracked over 3 min to observe localization. Fluorescence intensity profiles were generated using Slidebook6 software (n = 30 from three experimental repeats). Error bars, 1 SD.\
(E) H2AX^+/+^ and H2AX^−/−^ mouse embryonic fibroblasts were reverse transfected with 53BP1 siRNA. 24 hr later, cells were transfected with either the eYFP-SV40~NLS~-53BP1-BRCT~2~ construct or the eYFP-SV40~NLS~ control. 16 hr after this, cells were damaged using laser micro-irradiation. eYFP fluorescence was tracked over 3 min to observe localization. Scale bar, 10 μm.\
(F) Fluorescence intensity profiles from (E) were generated using Slidebook6 software (n = 30 from three experimental repeats). Error bars, 1 SD.\
(G) eYFP-SV40~NLS~-53BP1-BRCT~2~ was immunoprecipitated using GFP-trap beads (ChromoTek), from benzonase-treated, γ-irradiated HeLa cell lysates, and eYFP-SV40~NLS~-53BP1-BRCT~2~ or γH2AX detected by western blot. Inputs represent 1/1,000 of the total sample used in the immunoprecipitation.](gr2){#fig2}

![Co-localization of pATM Is Disrupted in 53BP1-BRCT~2~ Phospho-Binding Mutants\
(A) HeLa cells were reverse transfected with 53BP1 siRNA. 48 hr later, cells were transfected with an siRNA-resistant construct containing wild-type HA-53BP1, one of the BRCT mutants, or a Tudor domain mutant (Y1502L). 16 hr after this, cells were exposed to either 8 Gy for mock and wild-type (WT) or 3 Gy of ionizing radiation for the mutants and allowed to recover for 24 hr before staining for HA and NBS1. Scale bar, 5 μm.\
(B) As (A) but stained for pATM.\
(C) Cells processed in (A) and (B) were analyzed by measuring foci intensity of HA, pATM, and NBS1 (n = 30). Foci intensities were normalized to the average wild-type foci intensity for their respective channel. Normalized HA foci intensities from cells transfected with either WT or BRCT mutants indicates comparable expression of the plasmid constructs. Graph shows average of three experiments with 1 SD.](gr3){#fig3}

![Slow Repair of Damage in Heterochromatin Is Defective in 53BP1-BRCT~2~ Phospho-Binding Mutants\
(A) HeLa cells were reverse transfected with 53BP1 siRNA. 48 hr later, cells were transfected with an siRNA-resistant construct containing wild-type HA-tagged 53BP1 or one of the BRCT mutants. 16 hr later, cells were exposed to 3 Gy of ionizing radiation and allowed to recover for the indicated time before staining for HA-53BP1 and γH2AX. Higher numbers of γH2AX foci were evident 24 hr after irradiation in siRNA-treated cells and siRNA-treated cells transfected with 53BP1 mutant constructs.\
(B) Quantitation of γH2AX focus persistence. Graphs show the mean of three experiments; error bars, 1 SD. 53BP1 constructs lacking the BRCT domain or with point mutations that abrogate γH2AX binding in vitro show significantly higher levels of persistent γH2AX foci than wild-type (one-way ANOVA).\
(C) As (A) but with 53BP1 and/or KAP-1 siRNA. Persistence of significantly higher levels of γH2AX foci in the presence of 53BP1 mutants is suppressed when KAP-1 is also knocked down, indicating that persistence is due to a defect in KAP-1 phosphorylation by ATM as a result of the failure of the 53BP1 mutants to localize pATM to heterochromatinized sites of damage.](gr4){#fig4}
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